Presynaptic and postsynaptic relations of μ-opioid receptors to γ- aminobutyric acid-immunoreactive and medullary-projecting periaqueductal gray neurons

Journal of Comparative Neurology

Volumn 419, Issue 4, 2000, Pages 532-542

  Commons, Kathryn G ^a,c   Aicher, Sue A ^b   Kow, Lee Ming ^a   Pfaff, Donald W ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Analgesia; Enkephalin; Mesencephalon; Morphine; Pain

Indexed keywords

4 AMINOBUTYRIC ACID;

ANALGESIA; ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; DENDRITIC CELL; GABAERGIC TRANSMISSION; IMMUNOREACTIVITY; LIGAND BINDING; MESENCEPHALON; MOTOR COORDINATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; POSTSYNAPTIC INHIBITION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SYNAPTIC TRANSMISSION;

ANIMALS; GAMMA-AMINOBUTYRIC ACID; MALE; MEDULLA OBLONGATA; NEURAL PATHWAYS; PERIAQUEDUCTAL GRAY; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU; SYNAPSES;

EID: 0034678918     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(20000417)419:4<532::AID-CNE8>3.0.CO;2-6     Document Type: Article

References (43)

1. Abols IA, Basbaum AI. 1981. Afferent connections of the rostral medulla of the cat: a neural substrate for midbrain-medullary interactions in the modulation of pain. J Comp Neurol 201:285-297.
2. Aicher SA, Reis DJ. 1997. Gigantocellular vasodepressor area is tonically active and distinct from caudal ventrolateral vasodepressor area. Am J Physiol 272:R731-R742.
3. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf MW, Elde R. 1995. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328-3341.
4. Bandler R, Keay KA. 1996. Columnar organization in the midbrain periaqueductal gray and the integration of emotional expression. Progr Brain Res 107:285-300.
5. Bandler R, Shipley MT. 1994. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci 17:379-389.
6. Basbaum AI, Fields HL. 1978. Endogenous pain control mechanisms: review and hypothesis. Ann Neurol 4:451-462.
7. Basbaum AI, Fields HL. 1984. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309-338.
8. Behbehani MM. 1995. Functional characteristics of the midbrain periaqueductal gray. Progr Neurobiol 46:575-605.
9. Behbehani MM, Jiang M, Chandler SD. 1990. The effect of (Met]enkephalin on the periaqueductal gray neurons of the rat: an in vitro study. Neuroscience 38:373-380.
10. Beitz AJ, Mullett MA, Weiner LL. 1983. The periaqueductal gray projections to the rat spinal trigeminal, raphe magnus, gigantocellular pars alpha and paragigantocellular nuclei arise from separate neurons. Brain Res 288:307-314.
11. Bellgowan PS, Helmstetter FJ. 1996. Neural systems for the expression of hypoalgesia during nonassociative fear. Behav Neurosci 110:727-736.
12. Cannon JT, Prieto GJ, Lee A, Liebeskind JC. 1982. Evidence for opioid and non-opioid forms of stimulation-produced analgesia in the rat. Brain Res 243:315-321.
13. Carlton SM, Leichnetz GR, Young EG, Mayer DJ. 1983. Supramedullary afferents of the nucleus raphe magnus in the rat: a study using the transcannula HRP gel and autoradiographic techniques. J Comp Neurol 214:43-58.
14. Chan J, Aoki C, Pickel VM. 1990. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113-127.
15. Chen L, Huang LY. 1991. Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 7.319-326.
16. Chieng B, Christie MJ. 1994a. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br J Pharmacol 113:121-128.
17. Chieng B, Christie MJ. 1994b. Inhibition by opioids acting on mu-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Br J Pharmacol 113:303-309.
18. Christie MJ, Williams JT, Osborne PB, Bellchambers CE. 1997. Where is the locus in opioid withdrawal? Trends Pharmacol Sci 18(4):134-140.
19. Commons KG, Van Bockstaele EJ, Pfaff DW. 1999a. Colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J Comp Neurol, 408(4):549-559.
20. Commons KG, Kow LM, Milner TA, Pfaff DW. 1999b. In the ventromedial nucleus of the rat hypothalamus, GABA-immunolabeled neurons are abundant and are innervated by both enkephalin-and GABA-immunolabeled axon terminals. Brain Res 816:58-67.
21. Depaulis A, Morgan MM, Liebeskind JC. 1987, GABAergic modulation of the analgesic effects of morphine microinjected in the ventral periaqueductal gray matter of the rat. Brain Res 436:223-228.
22. Gallager DW, Pert A. 1978. Afferents to brain stem nuclei (brain stem raphe, nucleus reticularis pontis caudalis and nucleus gigantocellularis) in the rat as demonstrated by microiontophoretically applied horseradish peroxidase. Brain Res 144:257-275.
23. Holstege G. 1888. Direct and indirect pathways to lamina I in the medulla oblongata and spinal cord of the cat. Progr Brain Res 77:47-94.
24. Holstege G, Bandler R, Saper CB. 1996. The emotional motor system. Progr Brain Res 107:3-6.
25. Jacquet YF, Lajtha A. 1973. Morphine action at central nervous system sites in rat: analgesia or hyperalgesia depending on site and dose. Science 182:490-492.
26. Kalyuzhny AE, Wessendorf MW. 1997. CNS GABA neurons express the mu-opioid receptor: immunocytochemical studies. Neuroreport 8:3367-3372.
27. Kalyuzhny AE, Wessendorf MW. 1998. Relationship of mu-and deltaopioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits. J Comp Neurol 392:528-547.
28. Kalyuzhny AE, Arvidsson U, Wu W, Wessendorf MW. 1996. Mu-opioid and delta-opioid receptors are expressed in brainstem antinociceptive circuits: studies using immunocytochemistry and retrograde tracttracing. J Neurosci 16:6490-6503.
29. Keay KA, Crowfoot LJ, Floyd NS, Henderson LA, Christie MJ, Bandler R. 1997. Cardiovascular effects of microinjection of opioid agonists into the 'depressor region' of the ventrolateral periaqueductal gray region. Brain Res 762:61-71.
30. Kow L-M, Commons KG, Ogawa S, Pfaff DW. 1998. Potentiation of the excitatory action of NMDA in the ventrolateral periaqueductal gray (vlPAG) by the mu-opioid receptor (MOR) agonist DAMGO. Soc Neurosci Abstr 446:13.
31. Moreau JL, Fields HL. 1986. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res 397:37-46.
32. Morgan M. 1991. Differences in antinociception evoked from dorsal and ventral regions of the caudal periaqueductal gray matter. In: Depaulis A, Bandler R, editors. The midbrain periaqueductal gray matter. New York: Plenum Press, p 139-150.
33. Morgan MM, Heinricher MM, Fields HL. 1992. Circuitry linking opioid-sensitive nociceptive modulatory systems in periaqueductal gray and spinal cord with rostral ventromedial medulla. Neuroscience 47:863-871.
34. Ogawa S, Kow LM, Pfaff DW. 1994. In vitro electrophysiological characterization of midbrain periaqueductal gray neurons in female rats: responses to GABA-and Met-enkephalin-related agents. Brain Res 666:239-249.
35. Osborne PB, Vaughan CW, Wilson HI, Christie MJ. 1996. Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J Physiol 490:383-389.
36. Pert A, Yaksh T. 1975. Localization of the antinociceptive action of morphine in primate brain. Pharmacol Biochem Behav 3:133-138.
37. Reichling DB, Basbaum AI. 1990. Contribution of brainstem GABAergic circuitry to descending antinociceptive controls: I. GABA-immunoreactive projection neurons in the periaqueductal gray and nucleus raphe magnus. J Comp Neurol 302:370-377.
38. Reynolds DV. 1969. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science 164:444-445.
39. Swanson LW. 1992. Brain maps: structure of the rat brain. New York: Elsevier.
40. Vaughan CW, Ingram SL, Connor MA, Christie MJ. 1997. How opioids inhibit GABA-mediated neurotransmission. Nature 390(6660):611-614.
41. Williams FG, Beitz AJ. 1990a. Ultrastructural morphometric analysis of GABA-immunoreactive terminals in the ventrocaudal periaqueductal grey: analysis of the relationship of GABA terminals and the GABAA receptor to periaqueductal grey-raphe magnus projection neurons. J Neurocytol 19:686-696.
42. Williams FG, Beitz AJ. 1990b. Ultrastructural morphometric analysis of enkephalin-immunoreactive terminals in the ventrocaudal periaqueductal gray: analysis of their relationship to periaqueductal gray-raphe magnus projection neurons. Neuroscience 38:381-394.
43. Yaksh TL, Yeung JC, Rudy TA. 1976. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res 114: 83-103.